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Overexpression of HOXB3 in Hematopoietic Cells
Causes Defective Lymphoid Development
and Progressive Myeloproliferation
Guy Sauvageau,1, 3, 5 Unnur Thorsteinsdottir,1, 5 can differentiate and give rise to “committed progeni-
tors,” which progressively acquire the specialized char-Margaret R. Hough,1, 5, 6 Patrice Hugo,3
acteristics of one of the ten lineages that constituteH. Jeffrey Lawrence,4 Corey Largman,4
human hematopoiesis (Jordan and Lemischka, 1990;and R. Keith Humphries1, 2
Keller and Snodgrass, 1990).1Terry Fox Laboratory
While much progress has been made in identifyingBritish Columbia Cancer Agency
cytokines that can regulate the cycling status of primi-2Department of Medicine
tive hematopoietic cells, little is knownabout the geneticUniversity of British Columbia
mechanisms directing self-renewal and differentiationVancouver, British Columbia
outcomes of these early cells. Accumulating evidence,Canada, V5Z 1L3
however, points to transcription factors such as AML-13 Institut de Recherches Cliniques de Montre´al
(Okuda et al., 1996), Ikaros (Georgopoulos et al., 1994),Montre´al, P.Q.
SCL/Tal-1 (Shivdasani et al., 1995), Rbtn-2 (Warren etCanada, H2W 1R7
al., 1994), PU-1 (Scott et al., 1994), GATA-2 (Tsai et al.,4Department of Medicine
1994), and HOX homeobox genes (Sauvageau et al.,Veterans Affairs Medical Center
1995) as important regulators of these processes.and University of California, San Francisco
The HOX/HOM-C family of homeobox genes was ini-San Francisco, California 94121
tially described in Drosophila as master regulators of
embryonic cell proliferation and differentiation. In mam-
mals, at least 39 different HOX genes are grouped on
Summary four separate chromosomes (i.e., four clusters A to D).
As each HOX cluster is believed to have originated by
HOXB3 mRNA levels are high in the earliest CD341 duplication, it is possible to align individual members
lineage2 bone marrow cells and low to undetectable by homology. Genes belonging to the same homology
in later CD341/CD342 cells. To gain some insight into group are named paralogs (n 5 13), and they share a
similar pattern of expression in the developing embryo.the role this gene may play in hematopoiesis, HOXB3
More precisely, paralogs found in the 39 region of eachwas overexpressed in murine bone marrow cells using
of the HOX clusters, such as HOXA1, B1, and D1 (i.e.,retroviral gene transfer. Thymi of HOXB3 marrow re-
first paralogs) are expressed in the anterior structurescipients were reduced in size compared with control
of the embryo, whereas paralogs located in the 59 regiontransplant recipients, with a 24-fold decrease in the
(i.e., HOXA13, B13, C13, and D13) are expressed in moreabsolute number of CD41CD81 cells and a 3-fold in-
posterior structures.crease in the number of CD42CD82 thymocytes that
HOX genes are not only expressed in embryonic tis-contained a high proportion of gd TCR1 cells. B cell
sues. Their expression is also well documented in nor-differentiation was also perturbed in these mice, as
mal and neoplastic adult cells (Barba et al., 1993; Cilloindicated by the virtual absence of transduced IL-7-
et al., 1992; Friedmann et al., 1994; Manohar et al., 1993,responsive pre-B clonogenic progenitors. Recipients
1996; Peverali et al., 1990), including cells of the hemato-of HOXB3-transducedcells also hadelevated numbers
poietic system (reviewed by Lawrence and Largman,of mature granulocyte macrophage colony-forming
1992; Lawrence et al., 1996). By using a semiquantitativecells in their bone marrow and spleen. Together these
reverse transcriptase–polymerase chain reaction (RT–results suggest roles for HOXB3 in proliferation and
PCR) technique, we have recently shown that at leastdifferentiation processes of both early myeloid and
22 of the 39 known HOX genes are expressed at variouslymphoid developmental pathways.
levels in five different CD341 human bone marrow cell
subpopulations (Sauvageau et al., 1994), thus sug-
Introduction gesting that HOX genes might play critical roles in regu-
lating the proliferation or differentiation (or both) of the
earliest hematopoietic cells. In support of this are ourEvery day billions of mature specialized cells found in
recent findings that overexpression of HOXB4 in murinethe peripheral blood of a normal human adult need to
bone marrow cells markedly increased the regenerativebe replaced (Abkowitz et al., 1995). The burden of the
potential of long-term repopulating cells and caused anlife-long production of these mature elements is carried
expansion in clonogenic progenitor cell numbers, butout by a small number of primitive bone marrow cells
did not alter their ability to differentiate normally intoconstituting less than 0.01% of the total marrow (Har-
mature myeloid, erythroid, and lymphoid cells or causerison et al., 1993; Szilvassy et al., 1990). These primitive
abnormal end cell output (Sauvageau et al., 1995).cells have the key properties of being able to undergo
Although all HOX genes analyzed to date were pre-self-renewal, i.e., divide and give rise to progeny cells
dominantly expressed in CD341 bone marrow cells, thewith essentially the same biological properties, or they
expression of HOXB3 was restricted to phenotypically
primitive hematopoietic cells (i.e., CD341 and lineage
marker negative) representing less than 1% of all nucle-5These authors contributed equally to this work.
ated cells found in the bone marrow (Giampaolo et al.,6 Present address: Department of Laboratory Medicine, Sunnybrook
Health Science Center, Toronto, Ontario. 1994; Sauvageau et al., 1994).
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was isolated from a CD341 bone marrow expression
library. The predicted coding region of this HOXB3 cDNA
(GenBank accession number U59298) shares .97%
identity at the protein level over the coding region to
the mouse Hoxb-3 previously isolated from embryonic
tissue (Sham et al., 1992). The HOXB3 coding sequence
was subcloned into the MSCV 2.1 retroviral vector 59 to
a phosphoglycerate kinase promoter (pgk)-driven neo
gene such that HOXB3 expression was under the control
of the regulatory elements in the viral long terminal re-
peat (LTR) (Figure 1A). Integrity of this virus was shown
both by the expression of the expected 4.1 kb LTR-
derived full-length HOXB3 message in reconstituted
hematopoietic tissue of mice transplanted with HOXB3-
transduced bone marrow (Figure 1B) and by the pres-
ence of an unrearranged 4.1 kb proviral fragment
detected by Southern blot analysis of genomic DNA
isolated from bone marrow and thymus of such mice
(see Figure 3B).
Figure 1. Structure and Expression of the HOXB3 and neo Control
Retroviruses Used in This Study
Hematopoietic Reconstitution of Recipients(A) Diagrammatic representation of the integrated HOXB3 (upper)
of HOXB3-Transduced Bone Marrow Cellsand neo (lower) proviruses.
High titer, helper-free viral producer cell lines for either(B) Northern blot analysis of 5 mg of total RNA extracted from spleno-
cytes of mice 18 weeks after transplantation with neo- (left lane) or theHOXB3 ora neo control retrovirus wereused to infect
HOXB3-transduced (right lane) bone marrow cells. The membrane murine bone marrow cells as summarized in Figure 2.
was sequentially hybridized to a probe specific for neo and b-actin Immediately following retroviral infection, a proportion
and exposed for 48 hr. Two signals were obtained with the neo of the bone marrow cells was plated under G418 selec-
probe. The upper band represents long terminal repeat (LTR)-
tion in methylcellulose cultures supplemented with he-derived message of 2.7 and 4.1 kb for the neo and HOXB3 provirus,
matopoietic growth factors that support proliferationrespectively, and the lower band common to both constructs repre-
sents a 1.3 kb signal originating from the internal pgk promoter. and differentiation of myeloid and erythroid progenitors
(Figure 2A). The gene transfer efficiencies as assessed
by recovery of G418-resistant clonogenic progenitors
were from 15% to 50% in the three experiments. Analy-To explore further the function of HOXB3 in hemato-
poiesis, we analyzed the regeneration of various hema- ses of the cellular content of HOXB3-transduced colo-
nies (i.e., G418 resistant) showed all types of myeloidtopoietic compartments in mice transplanted with bone
marrow cells manipulated to overexpress the human or erythroid colonies (or both), suggesting that HOXB3
overexpressionwas permissive for invitro differentiationHOXB3 cDNA. In contrast with findings for HOXB4, over-
expression of HOXB3 impaired both B and T lymphoid of already committed myeloid progenitor cells (data not
shown).differentiation and enhanced proliferation of myeloid re-
stricted cells. To explore in more detail the possibility that HOXB3
might affect hematopoiesis, we examined reconstitution
of lymphoid and myeloid populations in lethally irradi-Results
ated mice transplanted with HOXB3-transduced bone
marrow cells. In three separate transplantation experi-cDNA Cloning of a HOXB3 Transcript from
Hematopoietic Cells and Generation of a ments, recipient mice (Ly5.21) were injected with a life-
sparing dose (200,000 cells) of congenic Ly5.11 boneHOXB3 Retroviral Vector
As is observed with many homeobox genes (Magli et marrow cells exposed to HOXB3 or neo retroviruses as
detailed in Figure 2. Based on our previous work usingal., 1991), HOXB3 has several transcripts, some of which
may be tissue specific (Sham et al., 1992). In an effort competitive repopulation assays, it was estimated that
each recipient received between 40 and 100 long-termto identify a HOXB3 transcript that is normally expressed
in primitive blood cells, a 3.2 kb human HOXB3 cDNA repopulating cells (Sauvageau et al., 1995), of which
Figure 2. Overview of Experimental Design
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presence of cells of the erythroid lineage, which are
negative for the expression of Ly5.1, rather than incom-
plete chimerism (Figure 3A). Furthermore, Southern blot
analysis of DNA isolated from the bone marrow and
thymus of these mice indicated a significant contribution
by transduced cells to this regeneration, as evidenced
by detection of the expected neo or HOXB3 proviral
signals at levels comparable with that of theendogenous
HOXB3 gene (Figure 3B).
Recipients of HOXB3-Transduced Cells
Show Increased Granulopoiesis in Their
Bone Marrow and Spleen
When analyzed 18–27 weeks after transplantation, age-
and sex-matched neo or HOXB3 mice had similar pe-
ripheral blood values (hemoglobin and white blood cells;
data not shown) and bone marrow cellularity (Figure 4A).
HOXB3 mice, however, showed a significant reduction
in thymic cellularity and a gradual increase in spleen
size over time (Figures 4Aand 4B). FACS analysis (Figure
5) and cytological examination (data not shown) of
spleen and bone marrow cells documented a consistent
increase in mature granulocytes in these tissues. In-
creased numbers of peripheral blood granulocytes were
also observed in some HOXB3 mice (Figure 5D, e.g.,
HOXB3-1 versus HOXB3-2). The absolute number of in
vitro myeloid colony-forming cells in bone marrow and
spleen of HOXB3 mice was increased 3-fold (Figure 4C),
consistent with the increase in bone marrow and spleen
mature granulocytes in these two tissues. Significantly,
between 50%–100% of these progenitors were G418
resistant, indicating that retrovirally transduced cells
Figure 3. Donor-Derived Hematopoietic Reconstitution of HOXB3 contributed substantially to these cell pools (Fig-
and neo Mice ure 4C).
(A) FACS analysis of proportion of donor-derived (Ly5.11) cells in Of the G418-resistant myeloid progenitors present in
various hematopoietic tissuesof HOXB3 (open bars) and neo (closed the bone marrow of these mice, between 10%and 100%
bars) mice. Results shown are mean 6 SD for n $ 6 mice.
generated small colonies (,100–200 cells) containing(B) Southern blot analysis of DNA isolated from bone marrow and
a mixture of greater than 95% mature and immaturethymi of HOXB3 (B3-1 to B3-6) or neo (neo-1 and neo-2) mice,
granulocytic cells, a colony type rarely detected in cul-sacrificed 18–25 weeks after transplantation. DNA was digested
with KpnI, which cuts once in each LTR of the integrated neo or tures initiated with cells from neo mice. The cellular
HOXB3 proviruses to release proviral fragments of 2.7 kb (neo) or content of larger G418-resistant colonies generated
4.1 kb (HOXB3). Donor-derived reconstitution (i.e., percent Ly5.1) from bone marrow of HOXB3 mice was similarly evalu-
of the mice shown in this figure varied between86%–98% for HOXB3
ated. Although all expected colony types were foundmice and 78%–94% for neo controls. The membrane was sequen-
(i.e., CFU-GEMM, CFU-GM, CFU-M, CFU-G, CFU-baso-tially hybridized to probes specific for neo (specific activity z30 3
phils-eosinophil, and BFU-E), the majority of these colo-106 dpm; 70 hr exposure time) and HOXB3 (specific activity not
measured; 24 hr exposure time). The endogenous HOXB3 signal is nies were either restricted to the granulocytic or macro-
detected at 1.4 kb. PBL, peripheral blood leukocytes; BM or B, bone phage lineage (or both) (46 of 54 large colonies examined
marrow; SPL, spleen; THY or T, thymus. from three mice). Thus, only 1 colony out of 54 was of
mixed lineage (CFU-GEMM), in contrast with 8 of the 21
such colonies from neo mice.
Together, these data suggest that HOXB3 caused the
expansion of more mature unilineage or bilineage my-approximately 20%–50% were estimated to be trans-
duced given the gene transfer efficiency to clonogenic eloid progenitors, but had minimal effect on the prolifer-
ation of earlier, multipotent cell types. This possibilityprogenitor cells in the transplant inoculum (see above).
Donor-derived (i.e., Ly5.11) reconstitution of hemato- was further assessed by limit dilution analysis to quanti-
tate the number of long-term repopulating cells presentpoietic tissues was assessed 14–30 weeks after trans-
plantation by fluorescence-activated cell sorting (FACS) in HOXB3 mice using the competitive repopulating unit
(CRU) assay (Szilvassy et al., 1990). By 18 weeks post-analysis (Figure 3A). Hematopoietic regeneration in ei-
ther HOXB3 or neo mice was essentially completely transplantation, CRU frequencies in recipients of neo or
HOXB3 transduced marrow were similar and, as ex-donor derived, since $80% of splenic, thymic, and pe-
ripheral blood leukocytes were of donor origin (Ly5.11; pected for experiments using transduced marrow, had
only regenerated to approximately 5% of normal levelsFigure 3A). The slightly lower levels that were detected
in bone marrow of neo mice presumably reflects the (frequencies of 0.3–1.0 or 0.3–2.0 per 105 bone marrow
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Figure 4. Hematopoietic Parameters of neo
and HOXB3 Mice
(A) Bone marrow, spleen, and thymic cellu-
larity of HOXB3 (open bars; n 5 13) and neo
mice (closed bars; n 5 8) 18–27 weeks after
transplantation.
(B) Increments in spleen weight in HOXB3
mice (closed bars) with time.
(C) Myeloid and pre-B lymphoid clonogenic
progenitor content in bone marrow and
spleen of neo (n 5 5) and HOXB3 (n 5 8) mice.
All results shown in (A)–(C) represent mean
values 6 SD. Double asterisk, significantly
decreased compared with neo control, p ,
0.005; single asterisk, significantly increased
compared with neo control, p , 0.05 (two-
tailed Student’s t test with unequal variance).
BM, bone marrow; SPL, spleen; THY, thymus.
cells for neo or HOXB3 mice, respectively). Thus, HOXB3 weeks posttransplantation having over 90% of CD42
CD82 or CD4loCD82 thymocytes (data not shown).overexpression, in contrast with that of HOXB4 (Sauva-
geau et al., 1995), does not appear to enhance the regen- HOXB3 overexpression was thus associated with an
apparent block in thymocyte maturation from the doubleerative potential of primitive long-term repopulating
cells. negative to the double positive stages coupled with
expansion of the CD4loCD82gd TCR1 and CD42CD82gd
TCR1 thymocytes (Figure 7).Recipients of HOXB3-Transduced Cells
Although the intensity of the proviral signal seen onHave Defective T Cell Development
Southern blot analysis of DNA extracted from wholeHOXB3 mice had significantly smaller thymi than age-
thymi of HOXB3 mice was consistent with high leveland sex-matched neo control recipients (Figure 4A), with
reconstitution by transduced cells (Figure 3B; all thymicorresponding abnormalities in the numbers and pro-
.80% CD4lo/2CD82 T cells), RT–PCR analysis was alsoportions of various subpopulations detected by flow
performed to assess proviral expression in various thy-cytometry (Figure 6). All recipients of HOXB3-infected
mic subpopulations of neo and HOXB3 mice. In contrastcells had abnormal CD4/CD8 profiles as evidenced by a
with neo control mice, in which strong to moderate ret-24-fold decrease in the proportion of CD41CD81 (double
roviral-derived signals were detected in all subpopula-positive) cells and a 6-fold decrease in a single posi-
tions, for HOXB3 mice retroviral-derived HOXB3 mRNAtive cell population (CD42CD81; Figure 6). In contrast,
were only detected at high levels in double negativethe proportions of CD42CD82 (double negative) and
thymocytes, at low to moderate levels in CD41CD82CD4loCD82 thymocytes were increased 3- and 2-fold,
(mostly CD4loCD81), and were not detectable in CD81respectively (Figure 6; data not shown). Although there
CD41 and CD81CD42 cells (Figure 8). These results thuswas some heterogeneity among mice analyzed, in most
suggest that HOXB3 overexpression is not compatiblemice (11 of 14) the majority of thymocytes were either
with progression from double negative to the doubleCD42CD82 or CD4loCD82. These cells expressed little
positive stage of thymic development and further indi-or no B220 or Mac-1 (in general ,3% each) and, mor-
cate that the few double positive thymocytes and theirphologically, were free of contaminating myeloid cells
progeny found in some HOXB3 mice were derived fromas assessed by cytospin preparations (data not shown).
either untransduced cells or HOXB3-transduced cells inThe dominant thymic CD42CD82 and CD4loCD82 popu-
which proviral expression was down-regulated.lations in these mice were heat-stable antigen–positive
To assess whether the perturbations in thymic devel-(HSAhi) and expressed variable levels of CD25 (interleu-
opment in HOXB3 mice extended into the periphery, Tkin-2 receptor a [IL-2Ra]; Figure 7; data not shown).
cells in peripheral blood, spleen, and lymph nodes wereCuriously, the majority of these cells were gd TCR1,
analyzed by flow cytometry (Figure 5). In all HOXB3 micewhereas few were of the ab lineage (Figure 7). There
analyzed (n 5 6), there werenormal distributions of CD41was a tendency for mice analyzed at later times (i.e.,
and CD81 single positive cells and essentially no.25 weeks posttransplantation) to have a more severe
thymic phenotype, with one mouse analyzed at 14 CD41CD81 T cells. Although these single positive cells
HOXB3 Overexpression Blocks ab T Cell Development
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Figure 5. Flow Cytometry Analysis of Cells Isolated from Hematopoietic Organs of HOXB3 or neo Control Mice
Bone marrow (A), spleen (B), lymph nodes (C), and peripheral blood leukocytes (D) were isolated from mice transplanted 18 weeks earlier
with HOXB3- or neo-transduced cells. HOXB3-1 and HOXB3-2 are two representative mice with moderate and severe phenotypes, respectively.
Numbers in boxes represent percentages of live cells found in this region. Lower numbers of cells were collected for analysis of lymph node
populations of the HOXB3-1 mouse (C).
were donor derived, it was not ascertained whether they resistant. This contrasts with both the high proportion of
transduced myeloid progenitors in these same HOXB3arose from transduced or nontransduced cells.
mice and that of pre-B progenitors in neo control mice
(Figure 4C). Furthermore, the rare G418-resistant colo-Altered B Cell Development by Overexpression
of HOXB3 nies derived from the HOXB3 mice were only approxi-
mately one tenth of normal size. Together, these resultsTo detect possible effects of HOXB3 overexpression
on B cell development, bone marrow IL-7-responsive B suggest that HOXB3 overexpression inhibits early B cell
development.lymphoid clonogenic progenitor numbers were mea-
sured. While the absolute numbers of these progenitors To characterize further possible B cell alterations in
HOXB3 mice, phenotypically distinct B cell populationsin HOXB3 mice were within the normal range (z7000
per femur; Figure 4C), only a small proportion were G418 were evaluated by flow cytometry using a combination
Immunity
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Figure 6. Cellularity of Thymi and Their Sub-
populations in Individual neo and HOXB3
Mice Sacrificed 18–27 Weeks after Trans-
plantation
neo and HOXB3 mice are indicated by
crosses and circles, respectively. Mean val-
ues are shown as horizontal lines. Ratios of
mean values for each thymic population in
neo and HOXB3 mice are indicated below
with p values (two-tailed Student’s t test with
unequal variance). One HOXB3 recipient was
omitted from this figure because it had exces-
sive values including 5.5 3 107 gd T cells (see
Discussion). Three mice analyzed at 25–27
weeks posttransplantation had .80% gd T
cells in their thymus, but since their exact
thymic cellularity is not available these mice
were not included in this figure. Contaminant
Mac-11 or B2201 cells were below 5% in all
thymic samples used for these analyses.
of monoclonal antibodies (anti-CD45R, anti-CD43, anti– an almost complete block in the thymic production of
CD41CD81 T lymphocytes, accompanied by an expan-immunoglobulin M [IgM], and anti-IgD) (Figure 5). Normal
proportions of the B cell subpopulations were seen in sion of gd TCR1 thymocytes, impaired B lymphoid devel-
opment, and enhanced myelopoiesis leading to a myelo-the peripheral blood and lymph nodes of HOXB3 mice
(Figure 5; profiles from two of five HOXB3 recipients proliferative disorder.
HOXB3-induced alterations were particularly promi-analyzed 18 weeks after transplantation); their propor-
tions were somewhat reduced in the spleen, but consid- nent in thymocyte development. The generation of ma-
ture ab T cells was blocked by overexpression ofering the increase in splenic cellularity, the absolute
number of B cells in this organ was within the normal HOXB3, as evidenced by reductions in double positive
and single positive thymocytes. Furthermore, the fewrange. Abnormalities were apparent, however, in the
bone marrow, where total B cells were consistently double positive thymocytes and their progeny found in
thymi of HOXB3 mice were negative for retroviral-reduced (Figure 5A) with marked variations (moder-
ate phenotype, HOXB3-1, and severe phenotype, derived HOXB3 expression, indicating either selection
for transduced cells in which there was spontaneousHOXB3-2). HOXB3 mice manifested a 2- to 10-fold re-
duction in total bone marrow B cells (B2201), with all B down-regulation of the LTR-driven expression or contri-
butions from untransduced cells. In contrast with thecell populations affected in those mice showing a more
severe phenotype (HOXB3-2, Figure 5). block in ab T cell maturation, the gd1 thymocytes in
HOXB3 mice were expanded (on average z4-fold). This
reached the extreme in one HOXB3 mouse that had aDiscussion
large thymus containing .97% HSA1 gd T cells. Since
we did not rule out the possibility that these cells hadOverexpression of HOXB3 had multiple effects onhema-
topoiesis as assessed in a bone marrow transplantation acquired pre-neoplastic properties as a result of addi-
tional somatic mutations, this mouse was not included inmodel. Specifically, overexpression of HOXB3 lead to
Figure 7. Flow Cytometry Analysis of Thymi
Isolated from Recipients of neo- or HOXB3-
Transduced Cells
One representative neo mouse and two rep-
resentative HOXB3 mice with moderate and
severe thymic phenotype are shown. CD4
and CD8 profiles of total thymocytes are
shown in the scatterplot (left). Each of the
histograms (right) illustrates a FACS profile
of 5000 CD42CD82 (double negative) cells
analyzed for their expression of ab and gd
TCR, IL-2 receptor (CD25), and HSA. Results
for all neo and HOXB3 mice analyzed (includ-
ing these) are presented in Figure 6.
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HOXB3 overexpression. This was apparent from the vir-
tual absence of transduced pre-B colony-forming cells
in bone marrow of HOXB3 mice and small colony size
from the few such progenitors detected. However, in
contrast with the findings in the thymus, the absolute
numbers of pre-B colony-forming cells in HOXB3 mice
were within normal range, presumably reflecting com-
petitive repopulation from nontransduced cells. Some
overall reduction in B cell content of the bone marrow
was seen, however, likely reflecting infiltration and dis-
placement by the expanding granulocytic populations
(Figure 5).
The defects in B and T cell development described
Figure 8. Expression by RT–PCR of Retroviral-Derived Genes in Pu- in this paper have not been reported with any other
rified Subpopulations of Thymocytes
molecules, including overexpression of another homeo-
Total RNA was isolated from FACS-purified thymic subpopulations
box gene Hlx, which caused a release of immature(10,000 cells persample) of HOXB3 or neo mice (n 5 4 separate mice;
CD41CD81 T cells in the periphery (Allen et al., 1995).only one representative of each is shown). The blot was sequentially
HOXB3 mice also developed a myeloproliferative dis-hybridized with a probe specific for b-actin (lower panel) and neo
(upper panel). Hybridization to a probe specific to HOXB3 gave order as evidencedby splenomegaly, a markedaccumu-
results superimposable to those obtained with the neo probe (data lation of myeloid clonogenic progenitors with granulo-
not shown). Note that double positive (CD41CD81) and single posi- cyte or macrophage differentiation potential (or both),
tive CD42CD81 cells from HOXB3 recipients do not express the
and by granulocytic infiltrationof bone marrow and otherretroviral-derived transcripts. Exposure times are 30 min for neo
hematopoietic organs. Forall HOXB3 mice analyzed (n 5and 1 hr for b-actin.
4) this myeloproliferative disorder was readily trans-
plantable to secondary recipients (data not shown).
Figure 6. The expanded gd TCR1 thymocytes in HOXB3 Most HOXB3 mice were sacrificed before 30 weeks and,
mice were distributed equally between CD42CD82 and in this time frame, progression of the myeloproliferative
CD4loCD82 populations and consisted predominantly of disorder to frank leukemia was not observed except for
cells expressing high levels of HSA, suggesting that they one mouse. Bone marrow clonogenic progenitor cells
represent an immature subset of gd T cells (Suda and from this mouse were all G418 resistant and showed
Zlotnik, 1993). growth factor independence in the presence of fetal
Together these results indicate that overexpression
calf serum. Studies to assess characterization of this
of HOXB3 has different effects on precursors of the ab
leukemia and further leukemic transformations that
TCR lineage than on those of the gd TCR lineage,
might develop in HOXB3 mice are currently underway.
blocking the maturation of the former while inducing
Although incomplete, these data nonetheless support
expansion of the latter. Whether these different effects
the accumulating evidence of HOX gene involvement in
reflect normal HOXB3 expression patterns in these cells
both murine and human leukemic transformation (Bor-
is currently unknown. While we have shown using an
row et al., 1996; Nakamura et al., 1996a, 1996b; Perkins
RT–PCR approach that the murine HOXB3 is normally
et al., 1990).expressed at very low levels in FACS-purified double
The results presented in this report stand in contrastnegative, double positive, and mature single positive
with ourprevious findings that overexpression of HOXB4thymocytes (G. S., unpublished data), its expression pat-
did not detectably perturb myeloid, B cell, or T cell differ-tern in subsets of double negative cells is currently un-
entiation, but did induce expansion of myeloid andknown. Further characterization of HOXB3 expression
lymphoid progenitor cells and enhanced up to 47-foldin these subsets will be of interest since this population
the regeneration of the most primitive hematopoieticcontains both mature gd T cells and precursors of both
repopulating cells (Sauvageau et al., 1995). These re-gd and ab lineages (Dudley et al., 1995).
sults also differ from our most recent findings that over-It is curious that the defect in thymocyte development
expression of HOXA10 in murine bone marrow cellsis not compensated by the nontransduced donor cells.
leads to enhanced formation of megakaryotic progeni-One possible explanation for this is that HOXB3-trans-
tors in vivo and in vitro, diminished numbers of macro-duced progenitors have a superior thymus repopulating
phage and B lymphoid progenitors, and generation ofability and therefore occupy the majority of the limited
myeloid leukemias in a significant proportion of micenumber of thymic niches (Spangrude and Scollay, 1990).
5–8 months after transplantation (Thorsteinsdottir et al.,Preferential niche occupation could also occur as a re-
1996). These findings demonstrate that very distinctivesult of other mechanisms, such as self-renewal advan-
effects result from the enforced expression of differenttages of HOXB3-transduced cells or active suppression
HOX genes in marrow cells (summarized in Figure 9).of normal thymocyte development by HOXB3-trans-
These observations, combined with our previousstudiesduced cells. This thymic defect does not appear to be
showing that HOX mRNA levels differ significantlydue to replacement by myeloid cells, since no myeloid
among various purified subpopulations of bone marrowinfiltration is seen cytologically and fewer than 5% of
cells, suggest that, as in embryonic development, HOXMac-11 cells are seen on FACS analysis of the thymi
genes are important regulators of early hematopoieticisolated from HOXB3 mice.
B lymphoid development was also impaired by developmental processes.
Immunity
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Figure 9. Schematic Representation of the
Effects Observed on Various Hematopoietic
Lineages with Overexpression of HOXB3,
HOXB4, or HOXA10
While HOXB4 selectively enhanced the re-
generative potential of primitive hemato-
poietic cells without altering their normal dif-
ferentiation, HOXB3 selectively blocked
differentiation of ab T cells and expanded
cells of the gd lineage. Overexpression of
HOXB3 also lead to myeloproliferation (gran-
ulocytic) and precluded the generation of
IL-7-responsive pre-B clonogenic progenitor
cells. Overexpression of HOXA10 caused
profound expansion (37-fold) of megakaryo-
cytic progenitors and impeded the generation
of unilineage macrophage or pre-B progeni-
tor cells.
Experimental Procedures of incubation as derived from CFU-GM, BFU-E, or CFU-GEMM ac-
cording to standard criteria (Humphries et al., 1981). In two experi-
ments, identification of colony types was confirmed by Wright stain-Mice
ing of cytospin preparations of colonies. For pre-B clonogenicRecipients of bone marrow cells were 7- to 12-week-old male or
progenitor assays, cells were plated in 0.8% methylcellulose in afemale (C57Bl/6J 3 C3H/HeJ)F1 ((B6C3)F1) anddonors were (C57Bl/
medium supplemented with 30% FSC, 1024 M b-ME, and 0.2 ng/ml6Ly-Pep3b 3 C3H/HeJ)F1 ((PepC3)F1). Hybrid F1 mice were bred
IL-7 (Suda et al., 1989). Pre-B colonies were scored on day 7 offrom parental strain breeders originally obtained from the Jackson
incubation. Evaluation of frequency of cells with long-term repopu-Laboratories (Bar Harbor,ME) and maintained in microisolatorcages
lating potential was done using the CRU assay (Szilvassy et al.,and provided with sterilized food and acidified water in the animal
1990). Technical modification of the procedures that were appliedfacility of the British Columbia Cancer Research Center. For bone
in this study have been reported previously (Sauvageau et al., 1995).marrow transplantation procedures, lethally irradiated (950 cGy, 110
cGy/min, 137Cs g-rays) (B6C3)F1 mice were injected intravenously
Antibodies, Flow Cytometry, and Cell Sortingwith 2 3 105 bone marrow cells from (PepC3)F1 mice immediately
A single cell suspension of bone marrow was prepared by injectingafter their cocultivation with HOXB3 or neo viral producer cells as
Hanks–HEPES-buffered salt solution containing 2% fetal calf serumdescribed previously (Sauvageau et al., 1995). This number of cells
and 0.1% sodium azide (HFN) into femurs to flush out cells, followedwas sufficient to spare 100% of the recipients, while death normally
by gentle disaggregation through a 21-gauge needle. Cells wereoccurred at approximately 14 days in the absence of donor cells.
released from the thymus, spleen, and lymph nodes by disruption
through a fine steel mesh. To lyse erythrocytes, cell suspensions
Retroviral Generation and Infection of Primary Bone were treated with 0.165 M NH4Cl and washed once with HFN. Cells
Marrow Cells were stained with primary antibodies in HFN on ice for 30 min,
The HOXB3 cDNA region encompassing the complete coding se- washed twice with HFN, and resuspended in HFN containing 1 mg/
quence was isolated as a KpnI fragment and subcloned upstream ml propidium iodide. Flow cytometric analysis was performed using
of the pgk–neo cassette at the HpaI site of the MSCV 2.1 retroviral a FACSort or FACStar flow cytometer equipped with PC LYSISII
vector (provided by Dr. Robert Hawley, Sunnybrook Research Insti- software. For cell sorting, 10,000 cells were harvested and a propor-
tute, Toronto, Canada) using standard procedures (Davis et al., tion was reanalyzed for purity (.95%). Monoclonal antibodies
1994). High titer helper-free recombinant retroviruses were gener- (MAbs) were titered and used as described previously (Hough et
ated and tested as previously described (Sauvageau et al., 1995). al., 1994, 1996). FITC-labeled CD4, CD8, gd TCR, CD43 (S7), GR-1;
PE-labeled IL-2Ra, CD4, CD8, B220; and biotinylated ab TCR MAbsThe generation of the neo retrovirus has already been described
were purchased from Pharmingen. HSA was detected by a cyanineelsewhere (Sauvageau et al., 1995). Bone marrow cells obtained
5-succinimidylester (Cy5)-labeled M1/69 MAb purified from thefrom (PepC3)F1 (Ly5.1) mice injected intravenously 4 days pre-
TIB125 hybridoma (American Type Culture Collection). The Mac-1viously with 150 mg per kilogram of body weight of 5-fluorouracil
MAb was purified from the M1/70.15.11 hybridoma (American Typewere prestimulated and cocultivated on irradiated viral producer
Culture Collection) and labeled with FITC. FITC-labeled mouse IgMcells in the presence of IL-3, steel, IL-6, and polybrene as described
and PE-labeled mouse IgD were purchased from Southern Biotech-previously (Sauvageau et al., 1995). Loosely adherent andnonadher-
nology. PE- and FITC-conjugated streptavidin were purchased froment cells were recovered from the cocultures and injected into a
Jackson ImmunoResearch Laboratories.lateral tail vein of recipient mice or directly cultured in vitro as de-
For mice analyzed at 14 weeks after transplantation (n 5 6), stain-scribed below.
ing was performed as described elsewhere (Hugo et al., 1993). In
brief, 106 cells prepared in PBS, 2% fetal calf serum, 0.1 % NaN3
In Vitro Clonogenic Progenitor and CRU Assays (PBSWB) were deposited in microculture wells. After centrifugation,
For myeloid clonogenic progenitor assays, cells were plated on 35 the pellet was resuspended in 10 ml of a blocking cocktail containing
mm petri dishes (Greiner, Federal Republic of Germany) in a 1.1 5 mg/ml of human g-globulins (Sigma) diluted in supernatant from
ml culture mixture containing 0.8% methylcellulose in a medium the hybridoma 2.4G2, which produces a MAb against the FcRIIb/III
supplemented with 30% fetal calf serum (GIBCO BRL), 1% bovine (Unkeless, 1979) and incubated for 5 min at 238C. A cocktail of 40
serum albumin, 1024 M b-mercaptoethanol (b-ME), 3 U/ml human ml of PBSWB containing FITC-conjugated anti-TCR (GL3-1.4; Gorski
urinary erythropoietin, and 2% spleen cell–conditioned medium in et al., 1993), PE-conjugated anti-CD4 (GK.15; GIBCO BRL), red 613–
the presence or absence of 1.4 mg/ml G418 as described. Bone conjugated anti-CD8 (GIBCO BRL), and biotinylated-anti-TCRa
marrow cells harvested from the cocultivation with virus producer (H57-597; Kubo et al., 1989) MAbs at the appropriate concentrations
cells or from reconstituted neo or HOXB3 mice were plated at a was added. After a 25 min incubation at 48C, the cells were washed
concentration of 1 3 103 to 2 3 103 cells per dish or 4 3 104 cells three times and resuspended in 50 ml of PBSWB with streptavidin-
per dish, respectively. Spleen cells from HOXB3 or neo mice were conjugated red 670 (GIBCO BRL). The cells were subsequently incu-
bated for an additional 30 min period, washed, and resuspended inplated at 1 3 106 cells per dish. Colonies were scored on days 10–14
HOXB3 Overexpression Blocks ab T Cell Development
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PBSWB to allow analysis on a Coulter XLTM flow cytometer Boncinelli, E. (1992). HOX gene expression in normal and neoplastic
human kidney. Int. J. Cancer 51, 892–897.equipped with a 488 nm laser beam and fluorescence detectors at
525, 575, 620, and 670 nm. For all cytofluorometric analyses done Davis, L., Kuehl, M., and Battey, J. (1994). Subcloning fragments into
at 14 weeks posttransplantation, a minimum of 150,000 events were plasmid vectors. In Basic Methods in Molecular Biology (Norwalk,
acquired. Connecticut: Appleton and Lange), pp. 277–302.
Dudley, E.C., Girardi, M., Owen, M.J., and Hayday, A.C. (1995). ab
cDNA Generation, Amplification, and Analysis and gd T cells can share a late common precursor. Curr. Biol. 5,
Reverse transcription and amplification of total messenger RNA 659–669.
isolated from the purified subpopulation was done exactly as pre-
Friedmann, Y., Daniel, C.A., Strickland, P., and Daniel, C.W. (1994).viously reported (Sauvageau et al., 1994). In brief, 10,000 thymocytes
Hox genes in normal and neoplastic mouse mammary gland. Cancerpurified by cell sorting were pelleted and lysed in 100 ml of 5 M
Res. 54, 5981–5985.guanidinium isothiocyanate solution. Nucleic acids were then pre-
Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Wi-cipitated and subsequent synthesis of the cDNA was done with a
nandy, S., and Sharpe, A. (1994). The Ikaros gene is required for the60-mer primer containing a 39 poly thymidine stretch as described
development of all lymphoid lineages. Cell 79, 143–156.(Brady et al., 1990). A short poly-adenosine tail was added to the
39 end of the first strand cDNA using terminal deoxynucleotidyl Giampaolo, A., Sterpetti, P., Bulocrini, D., Samoggia, P., Pelosi, P.,
transferase, and the second strand synthesis and subsequent PCR Valtieri, F., and Peschle, C. (1994). Key functional role and lineage-
amplification were done by PCR with the same primer (but at a specific expression of HOXB cluster genes in purified hematopoietic
higher concentration) as used during the reverse transcription (Sau- progenitor differentiation. Blood 84, 3637–3647.
vageau et al., 1994). Amplified total cDNA was size fractionated on Gorski, D.H., LePage, D.F., Patel, C.V., Copeland, N.G., Jenkins,
a 1% agarose gel, transferred to nylon membranes and hybridized N.A., and Walsh, K. (1993). Molecular cloning of a diverged homeo-
as described below. box gene that is rapidly down-regulated during the G0/G1 transition
in vascular smooth muscle cells. Mol. Cell. Biol. 13, 3722–3733.
DNA and RNA Analyses
Harrison, D.E., Jordan, C.T., Zhong, R.K., and Astle, C.M. (1993).Southern blot analyses to assess proviral integration were per-
Primitive hemopoietic stem cells: direct assay of most productiveformed using standardtechniques (Pawliuk et al., 1994). High molec-
populations by competitive repopulation with simple binomial, cor-ular weight DNA was digested with KpnI, which cuts in the LTRs
relation and covariance calculations. Exp. Hematol. 21, 206–219.to release the proviral genome. Total cellular RNA was isolated,
Hough, M.R., Takei, F., Humphries, R.K., and Kay, R. (1994). Defec-transferred, and hybridized as described (Sauvageau et al., 1995).
tive development of thymocytes overexpressing the costimulatoryProbes used were a XhoI–SalI fragment of pMC1neo (Thomas and
molecule, heat-stable antigen. J. Exp. Med. 179, 177–184.Capecchi, 1987), a 307 bp cDNA fragment 39 to HOXB3 homeobox
obtained by ApaI–BamHI restriction digestion, and a 2.0 kb PstI–PstI Hough, M.R., Chappel, M.S., Sauvageau, G., Takei, F., Kay, R., and
chicken b-actin fragment. Probes were labeled as described with Humphries, R.K. (1996). Reduction of early B lymphocyte precursors
[a-32P]dCTP and random primers (Sauvageau et al., 1994). in transgenic mice overexpressing the murine heat-stable antigen.
J. Immunol. 156, 479–488.
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